VRC 018 HIV 2/11/2019 - 2/10/2021 vaccine research center clinical monitoring initiative
Ended Awarded Last action
- Contract number
- 75N93019F00131
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $82,113
Award facts
- Opportunity
-
- NIHAO2017058 Solicitation number
- Vaccine Research Center Clinical Monitoring Initiative Award Notice · Posted Dec 8, 2016
- Vaccine Research Center Clinical Site Monitoring Services Initiative Award Notice · Posted Nov 17, 2016
- Contract value 86% obligated
-
- $82,113.11 Current, with exercised options
- $95,996.11 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$26,075 | |
| Other Administrative Action | $0 | |
| Original award | $108,188 |
About this award
This is a delivery order for the Vaccine Research Center Clinical Monitoring Initiative, issued by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID). The $95,996.11 task order was awarded to the prime contractor, The Emmes Company LLC, a for-profit limited liability company that specializes in providing data management, statistical analysis, and clinical trial support services to federal agencies, particularly NIH institutes. This task order supports the broader $545.5 million Comprehensive and Rapid Response for NIAID Research Programs indefinite delivery vehicle that Emmes holds to provide a variety of clinical research services, including protocol monitoring, data safety monitoring, and project management for NIAID's infectious disease research initiatives. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N93019F00131?
75N93019F00131 was awarded to The Emmes Company, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 6, 2019.
How much is contract 75N93019F00131 worth?
The government has obligated $82,113 on 75N93019F00131. Its potential value, with all options, is $95,996.
Is contract 75N93019F00131 an order under another contract?
Yes. 75N93019F00131 is a delivery order under HHSN272201700051I, an indefinite delivery contract, on VRC Clinical Monitoring Initiative 2017-2024.
Was contract 75N93019F00131 competed?
The extent of competition for 75N93019F00131 was full and open competition after exclusion of sources. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award